Rilzabrutinib Shows Promise In Treating Blood DyscrasiaMyhealthyclick · 10:58 18 Apr 2022In Phase 1-2 trial, rilzabrutinib has shown promising safety and efficacy in treating a blood disorder called immune thrombocytopenia, which is characterized by low levels of the blood cells… Read More